Medtech Published on April 16, 2020 COVID-19: a new laboratory essential to study coronavirus. Containment Laboratory 3 at the CHU Research Centre of Quebec City – Laval University is a timely addition to the laboratory. Read more on Le Soleil
Biotech Published on April 16, 2020 Researchers at Laval University have shown that blueberry polyphenols reduce weight gain through the intestinal microbiota. This is what they report in a study just published in the American Journal of Physiology – Endocrinology and Metabolism. Read more on La Tribune
Partnering Published on April 16, 2020 In the context of the global pandemic, investigators from the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal are adapting their skills and their knowledge to work towards finding creative and bold solutions to counter COVID-19. Read more on News Wire
Partnering Published on April 16, 2020 Inno-3B is using its vertical agriculture platform to grow plants that will eventually be used in the manufacture of a drug and a vaccine against COVID-19. Read more on La terre de chez nous
R&D Published on April 16, 2020 A COVID-19 screening clinic, specifically dedicated to research in asymptomatic and confined individuals, is in operation on the campus of the Université du Québec à Trois-Rivières (UQTR), as part of the DECOPA research project. Read more on L'Hebdo Journal
Medtech Published on April 14, 2020 Artificial Respirator: a tool to help prioritize patients who need to be connected. A team from the Faculty of Medicine and the CERVO Research Centre of the CIUSSS de la Capitale-Nationale is developing a decision-support algorithm to help people who will have to make this serious decision. Read more on Le Soleil
Pharma Published on April 14, 2020 Laurent Pharmaceuticals to initiate world-first testing of LAU-7b in COVID-19 patients. Read more on Business Wire
Biotech Published on April 14, 2020 Spartan Bioscience obtains Health Canada approval for a rapid, portable COVID-19 test. Read more on News Wire
Partnering Published on April 14, 2020 Quebec institutions are joining scientific forces to develop an extraordinary passive plasma immunization program against VIDOC-19. Read more on Université de Montréal (UDEM)